Artiva Biotherapeutics, Inc. (ARTV) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 88.74M | 112.67M | 129.52M | 149.07M | 170M | 188.63M | 150.56M | 49.75M | 65.89M | 79.82M |
| Cash & Short-Term Investments | 86.78M | 108.01M | 122.97M | 142.37M | 165.96M | 185.43M | 146.63M | 46.56M | 62.13M | 76.97M |
| Cash Only | 20.95M | 26.7M | 25.51M | 28.47M | 30.4M | 40.23M | 55.88M | 34.25M | 48.2M | 53.5M |
| Short-Term Investments | 65.83M | 81.31M | 97.46M | 113.9M | 135.56M | 145.19M | 90.75M | 12.31M | 13.93M | 23.47M |
| Accounts Receivable | 0 | 0 | 879K | 30K | 0 | 146K | 701K | 1.46M | 1.72M | 1.76M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | 631.02 | 273.05 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.96M | 4.66M | 5.68M | 6.67M | 234K | 3.06M | 3.23M | 1.73M | 2.03M | 1.09M |
| Total Non-Current Assets | 17.21M | 18.27M | 19.34M | 20.32M | 21.26M | 20.95M | 75.03M | 26.16M | 24.27M | 25.29M |
| Property, Plant & Equipment | 16.3M | 17.36M | 18.46M | 19.83M | 20.79M | 20.43M | 21.51M | 22.73M | 23.37M | 24.64M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | 0.01x | 0.10x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 461K | 0 | 0 | 0 | 52.97M | 0 | 0 | 0 |
| Other Non-Current Assets | 919K | 919K | 418K | 499K | 474K | 525K | 556K | 3.43M | 905K | 650K |
| Total Assets | 105.95M | 130.94M | 148.86M | 169.39M | 191.26M | 209.58M | 225.6M | 75.91M | 90.16M | 105.11M |
| Asset Turnover | - | - | - | - | - | - | - | - | 0.00x | 0.02x |
| Asset Growth % | -44.6% | -37.52% | -34.01% | 123.14% | 112.14% | 99.38% | - | - | - | - |
| Total Current Liabilities | 10.88M | 13.09M | 11.12M | 10.77M | 12.2M | 12.25M | 13.29M | 10.83M | 10.37M | 12.23M |
| Accounts Payable | 2.29M | 0 | 848K | 1.22M | 2.04M | 1.12M | 1.22M | 823K | 1.48M | 614K |
| Days Payables Outstanding | 308.92 | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 3.04M | 3.06M | 3.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.56M | 10.03M | 1.46M | 5.91M | 73K | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 8.16x | 8.61x | 11.65x | 13.84x | 13.93x | 15.39x | 11.33x | 4.59x | 6.35x | 6.53x |
| Quick Ratio | 8.16x | 8.61x | 11.65x | 13.84x | 13.93x | 15.39x | 11.33x | 4.59x | 6.35x | 6.53x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.23M | 7.88M | 8.52M | 9.58M | 10.28M | 10.69M | 11.31M | 256.18M | 254.47M | 254.9M |
| Long-Term Debt | 7.23M | 7.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 8.52M | 9.58M | 10.28M | 10.61M | 11.23M | 11.97M | 12.61M | 13.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 73K | 73K | 244.21M | 241.85M | 241.59M |
| Total Liabilities | 18.11M | 20.97M | 19.64M | 20.35M | 22.48M | 22.94M | 24.6M | 267.01M | 264.83M | 267.13M |
| Total Debt | 10.26M | 10.94M | 11.69M | 13.22M | 14M | 14.35M | 14.97M | 15.77M | 16.26M | 16.91M |
| Net Debt | -10.69M | -15.76M | -13.82M | -15.24M | -16.41M | -25.88M | -40.91M | -18.48M | -31.94M | -36.59M |
| Debt / Equity | 0.12x | 0.10x | 0.09x | 0.09x | 0.08x | 0.08x | 0.07x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 87.85M | 109.97M | 129.22M | 149.04M | 168.78M | 186.64M | 201M | -191.1M | -174.67M | -162.01M |
| Equity Growth % | -47.95% | -41.08% | -35.71% | 177.99% | 196.63% | 215.2% | - | - | - | - |
| Book Value per Share | 3.56 | 4.50 | 5.28 | 6.11 | 6.93 | 7.66 | 8.28 | -8.21 | -9.93 | -7.93 |
| Total Shareholders' Equity | 87.85M | 109.97M | 129.22M | 149.04M | 168.78M | 186.64M | 201M | -191.1M | -174.67M | -162.01M |
| Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 0 | 0 | 0 |
| Retained Earnings | -354.06M | -330.55M | -309.78M | -288.25M | -267M | -246.68M | -230.59M | -213.12M | -195.27M | -181.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -18K | 103K | 87K | 2K | 0 | -129K | 338K | 121K | 207K | 308K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |